MedPath

Examination of efficacy of olmesartan on peripheral insulin sensitivity in Japanese patients with type 2 diabetes

Not Applicable
Conditions
Hypertension Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000005535
Lead Sponsor
Kumamoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

subjects treated with corticosteroids are excluded from this study. In addition, subjects with secondary hypertension, severe renal and hepatic disease, overt cardiovascular disease, or malignancy are excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath